SBIR/STTR Research Award
Measure of Dysfunctional Retinal Ganglion Cell Response
Award amount
$225,000Program and phase
SBIR · Phase IAward year
2018Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Valenti, Denise
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- L58PWFW1TQL1
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
NIH through NIDA solicits the research and development of digital markers for detection of marijuana intoxication and cognitive impairmentIn this project the Contractor will develop and clinically validate a technology that indirectly tests retinal ganglion cell functionThe sensory psychomotor signal in the smartphone application named IMMAD is a visual field test using a small square with stripes of low spatial frequency alternating at a high temporal frequencyhaving variable contrast and being flashed in one of nineteen regions in the central forty degrees of the visual fieldThe smartphone is set in a virtual reality goggle system to present the test at optical infinity and to eliminate environmental variables such as glare and reflectionThe Contractor will test it on participants who are using real world marijuana and validateIMMAD s sensitivity and refine the specificity to functional impairment with acute marijuana use
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)